Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

|Videos|May 30, 2023

Conventional Imaging for Prostate Cancer

Author(s)Phillip Koo, MD, Michael S. Cookson, MD, MMHC, FACS, Scott Sellinger, MD, FACS

Scott Sellinger, MD, FACS, shares a historical perspective on use of conventional imaging modalities in prostate cancer.

Episodes in this series

EP. 1 Risk Stratification of Patients with Prostate Cancer

EP. 1 Risk Stratification of Patients with Prostate Cancer

EP. 2 Conventional Imaging for Prostate Cancer

EP. 2 Conventional Imaging for Prostate Cancer

EP. 3 Introduction to PSMA-Targeted PET Imaging

EP. 3 Introduction to PSMA-Targeted PET Imaging

EP. 4 Approved PSMA-PET Imaging Tracer Options for Prostate Cancer

EP. 4 Approved PSMA-PET Imaging Tracer Options for Prostate Cancer

EP. 5 Practical Considerations for Selection of PSMA-PET Tracers

EP. 5 Practical Considerations for Selection of PSMA-PET Tracers

EP. 6 Impact of PSMA-Targeted Imaging Modalities on Management of Prostate Cancer

EP. 6 Impact of PSMA-Targeted Imaging Modalities on Management of Prostate Cancer

EP. 7 Overview of Available Clinical Guidelines on PSMA-PET Imaging in Prostate Cancer

EP. 7 Overview of Available Clinical Guidelines on PSMA-PET Imaging in Prostate Cancer

EP. 8 Challenges of Implementing PSMA-Targeted PET Imaging in Prostate Cancer

EP. 8 Challenges of Implementing PSMA-Targeted PET Imaging in Prostate Cancer

EP. 9 Navigating and Overcoming Challenges of PSMA-PET Imaging Results Interpretation

EP. 9 Navigating and Overcoming Challenges of PSMA-PET Imaging Results Interpretation

EP. 10 Best Practices for Communication: A Multidisciplinary Perspective

EP. 10 Best Practices for Communication: A Multidisciplinary Perspective

EP. 11 Navigating Virtual Tumor Boards for Prostate Cancer PSMA-PET Imaging

EP. 11 Navigating Virtual Tumor Boards for Prostate Cancer PSMA-PET Imaging

EP. 12 Unmet Needs in Imaging for Patients With Prostate Cancer

EP. 12 Unmet Needs in Imaging for Patients With Prostate Cancer

EP. 13 PSMA-Based Imaging and Theranostics: A Summary of Current Paradigm Shifts and a Look to the Future

EP. 13 PSMA-Based Imaging and Theranostics: A Summary of Current Paradigm Shifts and a Look to the Future

EP. 14 Closing Thoughts on the Impact of PSMA-PET Imaging in Prostate Cancer

EP. 14 Closing Thoughts on the Impact of PSMA-PET Imaging in Prostate Cancer

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Annual ACS NCDB report details national trends in prostate cancer care

ByHannah Clarke

January 27th 2026

Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA

ByAmy M. Pearlman, MD

January 26th 2026

Ridwan I. Alam, MD, MPH, discusses combining PHI and MRI to predict prostate cancer risk

ByRidwan I. Alam, MD, MPH

January 22nd 2026

CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction

ByHannah Clarke

January 21st 2026

Initial ARID results published in World Journal of Urology as pivotal trial progresses

ByHannah Clarke

January 20th 2026

Latest CME

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

Trending on Urology Times

Treatment Selection in Advanced Prostate Cancer

FDA provides guidance on development pathway for testosterone therapy for women

Annual ACS NCDB report details national trends in prostate cancer care

Advice for the Next Generation of Urologists in mCSPC Management

Strategic Use of ADT in mCSPC From Selection to Escalation